Abstract: The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from Hafnia alvei lipopolysaccharides, as well as conjugates of these polysaccharides with carriers and methods for their preparation and methods to use of these substances as ligands for human ficolin-3.
Type:
Grant
Filed:
June 11, 2011
Date of Patent:
July 5, 2016
Assignees:
INSTYTUT BIOLOGII MEDYCZNEJ POLSKIEJ AKADEMII NAUK, INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ PAN
Inventors:
Jolanta Lukasiewicz, Anna Swierzko, Maciej Cedzynski, Czeslaw Lugowski, Anna Maciejewska, Wojciech Jachymek, Tomasz Niedziela
Abstract: The invention relates to bacterial lipopolysaccharide and its components, especially native and chemically modified polysaccharides isolated from Hafnia alvei lipopolysaccharides, as well as conjugates of these polysaccharides with carriers and methods for their preparation and methods to use of these substances as ligands for human ficolin-3.
Type:
Application
Filed:
June 11, 2011
Publication date:
October 10, 2013
Applicants:
INSTYTUT BIOLOGII MEDYCZNEJ POLSKIEJ AKADEMII NAUK, INSTYTUT IMMUNOLOGII I TERAPII DOSWIADCZALNEJ PAN
Inventors:
Jolanta Lukasiewicz, Anna Swierzko, Maciej Cedzynski, Czeslaw Lugowski, Anna Maciejewska, Wojciech Jachymek, Tomasz Niedziela